ARTICLE | Company News
Novartis to spin out Alcon unit
July 13, 2018 6:57 PM UTC
Novartis AG (NYSE:NVS; SIX:NOVN) said it intends to spin out its Alcon eye care business, while retaining the pharma’s ophthalmology pharmaceuticals portfolio.
The spinout will include Alcon’s surgical and vision care assets, which yielded $6.7 billion in 2017 sales. Novartis expects the transaction to close in 1H19...
BCIQ Target Profiles